| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.29▲ | 2.30▼ | 2.30▼ | 2.26▲ | 2.28▼ |
| MA10 | 2.29▲ | 2.31▼ | 2.31▼ | 2.22▲ | 2.33▼ |
| MA20 | 2.30▲ | 2.31▼ | 2.30▼ | 2.27▲ | 2.11▲ |
| MA50 | 2.31▼ | 2.31▼ | 2.25▲ | 2.39▼ | 1.60▲ |
| MA100 | 2.31▼ | 2.24▲ | 2.26▲ | 2.05▲ | 1.87▲ |
| MA200 | 2.30▼ | 2.26▲ | 2.41▼ | 1.64▲ | 3.96▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.004▼ | -0.005▼ | 0.002▲ | -0.018▼ |
| RSI | 49.651▼ | 48.796▼ | 51.296▲ | 48.756▼ | 55.951▲ |
| STOCH | 16.667▼ | 18.559▼ | 46.154 | 56.926 | 27.999 |
| WILL %R | -16.667▲ | -73.913 | -65.385 | -52.381 | -75.172▼ |
| CCI | 21.569 | -90.784 | -53.552 | 53.539 | -12.957 |
|
Wednesday, May 06, 2026 08:43 AM
Conference Call and Webcast Scheduled for May 13, 2026 at 2 p.m. PT/5 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage ...
|
|
Friday, May 01, 2026 02:23 AM
Allogene Therapeutics Inc. (NASDAQ:ALLO) is a clinical-stage biotechnology company dedicated to the development of off-the-shelf allogeneic CAR-T cell therapies for cancer and autoimmune diseases. The ...
|
|
Saturday, April 25, 2026 02:06 PM
Allogene Therapeutics Inc. (NASDAQ:ALLO) is one of the best growth stocks under $10 to invest in. On April 21, Allogene Therapeutics received regulatory clearance to expand its pivotal Phase 2 ALPHA3 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/05/26 | 2.29 | 2.39 | 2.27 | 2.28 | 4,503,825 |
| 08/05/26 | 2.29 | 2.36 | 2.25 | 2.28 | 4,476,509 |
| 07/05/26 | 2.32 | 2.355 | 2.25 | 2.27 | 5,680,658 |
| 06/05/26 | 2.24 | 2.36 | 2.22 | 2.31 | 7,352,979 |
| 05/05/26 | 2.29 | 2.325 | 2.14 | 2.17 | 5,831,796 |
| 04/05/26 | 2.14 | 2.27 | 2.12 | 2.26 | 7,509,549 |
| 01/05/26 | 2.09 | 2.165 | 2.08 | 2.15 | 4,520,799 |
| 30/04/26 | 2.13 | 2.175 | 2.105 | 2.13 | 5,045,224 |
| 29/04/26 | 2.18 | 2.22 | 2.09 | 2.11 | 6,518,228 |
| 28/04/26 | 2.26 | 2.295 | 2.18 | 2.19 | 6,250,695 |
|
|
||||
|
|
||||
|
|